OCUGEN, INC. Shares Outstanding (Cover Page)
OCUGEN, INC. (OCGN) had Shares Outstanding (Cover Page) of 339.11 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 339.11M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 338.52M shares.
- 2026-02-24: Entity Common Stock, Shares Outstanding 327.90M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 312.32M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 339.11M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 338.52M shares 10-Q · filed 2026-05-08 |
| 2026-02-24 | 327.90M shares 10-K · filed 2026-03-04 |
| 2025-10-31 | 312.32M shares 10-Q · filed 2025-11-05 |
| 2025-07-28 | 292.30M shares 10-Q · filed 2025-08-04 |
| 2025-05-02 | 292.03M shares 10-Q · filed 2025-05-09 |
| 2025-02-26 | 292.01M shares 10-K · filed 2025-03-05 |
| 2024-11-12 | 291.32M shares 10-Q · filed 2024-11-14 |
| 2024-08-02 | 287.86M shares 10-Q · filed 2024-08-08 |
| 2024-05-07 | 257.33M shares 10-Q · filed 2024-05-14 |
| 2024-04-22 | 257.33M shares 10-K/A · filed 2024-04-29 |
| 2024-04-09 | 257.33M shares 10-K · filed 2024-04-16 |
| 2023-11-02 | 256.50M shares 10-Q · filed 2023-11-09 |
| 2023-08-14 | 256.49M shares 10-Q · filed 2023-08-21 |
| 2023-04-28 | 226.43M shares 10-Q · filed 2023-05-05 |
| 2023-02-21 | 226.42M shares 10-K · filed 2023-02-28 |
| 2022-11-01 | 218.89M shares 10-Q · filed 2022-11-08 |
| 2022-07-29 | 216.57M shares 10-Q · filed 2022-08-05 |
| 2022-04-29 | 215.66M shares 10-Q · filed 2022-05-06 |
| 2022-02-21 | 199.49M shares 10-K · filed 2022-02-28 |
| 2021-11-02 | 199.19M shares 10-Q · filed 2021-11-09 |
| 2021-07-30 | 198.76M shares 10-Q · filed 2021-08-06 |
| 2021-04-30 | 198.23M shares 10-Q · filed 2021-05-07 |
| 2021-03-01 | 188.09M shares 10-K · filed 2021-03-19 |
| 2020-10-30 | 162.03M shares 10-Q · filed 2020-11-06 |
| 2020-08-07 | 135.01M shares 10-Q · filed 2020-08-14 |
| 2020-05-01 | 74.55M shares 10-Q · filed 2020-05-08 |
| 2020-03-20 | 52.63M shares 10-K · filed 2020-03-27 |
| 2019-11-07 | 16.00M shares 10-Q · filed 2019-11-12 |
| 2019-08-06 | 94.60M shares 10-Q · filed 2019-08-09 |
| 2019-05-13 | 94.60M shares 10-Q · filed 2019-05-15 |
| 2019-03-20 | 94.60M shares 10-K · filed 2019-03-22 |
| 2018-11-06 | 62.03M shares 10-Q · filed 2018-11-08 |
| 2018-08-07 | 28.79M shares 10-Q · filed 2018-08-09 |
| 2018-05-08 | 28.69M shares 10-Q · filed 2018-05-10 |
| 2018-03-13 | 28.69M shares 10-K · filed 2018-03-15 |
| 2017-11-07 | 24.07M shares 10-Q · filed 2017-11-09 |
| 2017-08-08 | 22.49M shares 10-Q · filed 2017-08-10 |
| 2017-05-08 | 21.17M shares 10-Q · filed 2017-05-11 |
| 2017-03-14 | 22.17M shares 10-K · filed 2017-03-16 |
| 2016-11-08 | 15.93M shares 10-Q · filed 2016-11-10 |
| 2016-08-09 | 13.27M shares 10-Q · filed 2016-08-11 |
| 2016-05-10 | 13.27M shares 10-Q · filed 2016-05-12 |
| 2016-03-10 | 13.27M shares 10-K · filed 2016-03-10 |
| 2015-11-10 | 13.27M shares 10-Q · filed 2015-11-12 |
| 2015-08-10 | 13.24M shares 10-Q · filed 2015-08-12 |
| 2015-05-13 | 13.22M shares 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |